When to Perform Fetal Echocardiography
Fetal echocardiography should be performed at 18-22 weeks gestation for all Class I indications, with the option for early screening at 12-14 weeks in high-risk cases, though a repeat second-trimester study remains mandatory. 1, 2
Optimal Timing Window
The standard timing for comprehensive fetal echocardiography is 18-22 weeks gestation, when detection rates for congenital heart disease approach 80% in experienced centers and complete cardiac evaluation is achievable in over 90% of cases. 1, 2
Early fetal echocardiography can be performed at 12-14 weeks gestation (or as early as 11 weeks with transvaginal approach), detecting 50-65% of major cardiac anomalies in high-risk patients, though this early timing detects only about half of hypoplastic left heart and atrioventricular septal defects, and less than a quarter of conotruncal abnormalities. 1, 2
A repeat second-trimester fetal echocardiogram at 18-22 weeks is mandatory following any early first-trimester cardiac evaluation due to the limitations of early imaging and risk of both false-positive and missed diagnoses. 1, 2
Class I Indications (Strongest Evidence)
Fetal Factors
Abnormal-appearing heart on routine obstetric ultrasound examination, as 11 of 21 cases (52%) referred with suspected cardiac abnormality on obstetric scans are confirmed abnormal on detailed echocardiography. 1, 3
Fetal tachycardia, bradycardia, or irregular rhythm detected on clinical examination or screening ultrasound. 1
Nuchal translucency ≥3 mm or ≥99th percentile at 11-14 weeks, which warrants both genetic counseling and fetal echocardiography, with approximately 1% of first-trimester screening patients meeting this threshold. 1
Major extracardiac fetal abnormalities or chromosomal anomalies when pregnancy management decisions are required, as the incidence of congenital heart disease in fetuses with sonographic abnormalities is significantly elevated at 79.9 per 1000 compared to 6.9 per 1000 in low-risk populations. 1, 4
Non-immune hydrops fetalis, which requires cardiac evaluation to assess for structural abnormalities and functional decompensation. 5
Maternal Factors
Maternal pregestational diabetes mellitus, which increases fetal cardiac risk. 1
Maternal systemic lupus erythematosus or anti-Ro/SSA and/or anti-La/SSB antibody positivity, requiring serial fetal echocardiography beginning at 16-18 weeks and continuing through week 26, with weekly monitoring if there is a prior infant with congenital heart block (recurrence risk 13-18%) versus every 1-2 weeks for first pregnancies (risk approximately 2%). 1, 6
Teratogen exposure during vulnerable periods, including anticonvulsants or lithium in the first trimester, though the actual incidence of significant cardiac lesions in this group is low at 0.8%. 1, 7
Family History
Parent, sibling, or first-degree relative with congenital heart disease, though the incidence in this group (5.6 per 1000) is similar to the general population baseline of 8.0 per 1000 livebirths. 1, 4
Family history of left or right heart obstructive lesions, which carries specific inherited risk. 1
Additional Indications in Multiple Gestations
Monochorionic twins with twin-twin transfusion syndrome (TTTS) require fetal echocardiography, as the recipient twin demonstrates cardiac functional abnormalities and 3-10% develop right ventricular outflow obstruction either before or after laser ablation. 1
Twin reversed arterial perfusion (TRAP) sequence requires cardiac evaluation of the "pump" fetus to assess for volume overload, with up to 10% having congenital heart disease. 1
Selective fetal growth restriction in monochorionic twins warrants echocardiography when abnormal Doppler findings (absent or reversed end-diastolic flow) are present. 1
Important Caveats and Pitfalls
Historic risk factors alone (family history, maternal diabetes, teratogen exposure) without additional fetal findings have a low yield (0.8-6.9 per 1000), and routine screening in all women with these factors is not strongly supported by evidence, though guidelines still classify them as Class I indications. 1, 4, 7
First-trimester echocardiography has significant limitations with high rates of both false-positive and missed diagnoses, making it inappropriate as a standalone examination without second-trimester follow-up. 1, 2
The negative predictive value of fetal echocardiography is 96%, but 4% of cases with normal studies will have congenital heart disease detected postnatally, typically minor lesions. 3
Doppler studies in the first trimester should be reserved only for high-risk fetuses (nuchal translucency ≥3 mm) following ALARA principles to minimize fetal exposure. 1, 2
In obese women, anatomic studies should be performed at 20-22 weeks (approximately 2 weeks later than normal-weight women) with consideration of transvaginal imaging to improve completion rates. 1